Last Updated: September 28, 2026

Avyxa Holdings Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for AVYXA HOLDINGS

AVYXA HOLDINGS has twelve approved drugs.

There are five US patents protecting AVYXA HOLDINGS drugs.

Summary for Avyxa Holdings

US Patents:	5
Tradenames:	12
Ingredients:	12
NDAs:	12

Drugs and US Patents for Avyxa Holdings

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Avyxa Holdings	POSFREA	palonosetron hydrochloride	SOLUTION;INTRAVENOUS	203050-001	Mar 1, 2016		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Avyxa Holdings	BENDAMUSTINE HYDROCHLORIDE	bendamustine hydrochloride	SOLUTION;INTRAVENOUS	219014-001	Jul 3, 2025		RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
Avyxa Holdings	FAVLYXA	fluorouracil	SOLUTION;INTRAVENOUS	220201-001	Feb 20, 2026		RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for Avyxa Holdings Drugs

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2016005962	⤷ Start Trial
Poland	3270912	⤷ Start Trial
China	111728940	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for Avyxa Holdings Drugs

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0432677	7/2005	Austria	⤷ Start Trial	PRODUCT NAME: PEMETREXED UND DESSEN PHARMAZEUTISCH ANNAHMBAREN SALZE; REGISTRATION NO/DATE: EU/1/04/290/001 20040920
2785706	C02785706/01	Switzerland	⤷ Start Trial	PRODUCT NAME: FOSNETUPITANT, PALONOSETRON.; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68290 01.09.2022
0138504	2004C/004	Belgium	⤷ Start Trial	PRODUCT NAME: FULVESTRANT; REGISTRATION NO/DATE: EU/1/03/269/001 20040311
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Avyxa Holdings

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.